The global impact and cost-effectiveness of a melioidosis vaccine

被引：0
|
作者：
Nantasit Luangasanatip
Stefan Flasche
David A. B. Dance
Direk Limmathurotsakul
Bart J. Currie
Chiranjay Mukhopadhyay
Tim Atkins
Richard Titball
Mark Jit
机构：
[1] London School of Hygiene and Tropical Medicine,Department of Infectious Disease Epidemiology, Faculty of Epidemiology and Population Health
[2] University of Exeter,College of Life and Environmental Sciences
[3] Faculty of Tropical Medicine,Mahidol
[4] Mahidol University,Oxford Tropical Medicine Research Unit
[5] Lao-Oxford-Mahosot Hospital-Wellcome Trust Research Unit (LOMWRU),Centre for Tropical Medicine and Global Health, Nuffield Department of Clinical Medicine
[6] University of Oxford,Faculty of Infectious and Tropical Disease
[7] London School of Hygiene and Tropical Medicine,Department of Tropical Hygiene, Faculty of Tropical Medicine
[8] Mahidol University,Global and Tropical Health Division
[9] Menzies School of Health Research,Department of Infectious Diseases and Northern Territory Medical Program
[10] Royal Darwin Hospital,Department of Microbiology, Kasturba Medical College
[11] Manipal Academy of Higher Education,undefined
[12] Defence Science and Technology Laboratory,undefined
来源：
BMC Medicine | / 17卷
关键词：
Melioidosis; Infections; Vaccine; Cost-effectiveness; Economic evaluation;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] The global impact and cost-effectiveness of a melioidosis vaccine
    Luangasanatip, Nantasit
    Flasche, Stefan
    Dance, David A. B.
    Limmathurotsakul, Direk
    Currie, Bart J.
    Mukhopadhyay, Chiranjay
    Atkins, Tim
    Titball, Richard
    Jit, Mark
    [J]. BMC MEDICINE, 2019, 17
  • [2] COST-EFFECTIVENESS OF PNEUMOCOCCAL VACCINE
    RANGO, N
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1981, 304 (02): : 117 - 117
  • [3] COST-EFFECTIVENESS OF FLU VACCINE
    不详
    [J]. CONNECTICUT MEDICINE, 1982, 46 (10) : 607 - 607
  • [4] COST-EFFECTIVENESS OF PNEUMOCOCCAL VACCINE
    LEVY, E
    [J]. REVUE D EPIDEMIOLOGIE ET DE SANTE PUBLIQUE, 1981, 29 (02): : 133 - 153
  • [5] Cost-effectiveness analysis of parenteral antimicrobials for acute melioidosis in Thailand
    Hantrakun, Viriya
    Chierakul, Wirongrong
    Chetchotisakd, Ploenchan
    Anunnatsiri, Siriluck
    Currie, Bart J.
    Peacock, Sharon J.
    Day, Nicholas P. J.
    Cheah, Phaik
    Limmathurotsakul, Direk
    Lubell, Yoel
    [J]. TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE, 2015, 109 (06) : 416 - 418
  • [6] Optimal control and cost-effectiveness analysis for the human melioidosis model
    Engida, Habtamu Ayalew
    Gathungu, Duncan Kioi
    Ferede, Melkamu Molla
    Belay, Malede Atnaw
    Kawe, Patiene Chouop
    Mataru, Bilali
    [J]. HELIYON, 2024, 10 (04)
  • [7] Cost-effectiveness of pneumococcal vaccine - Reply
    Lieu, T
    Ray, GT
    Black, S
    Shinefield, H
    Butler, J
    Miller, M
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2000, 284 (04): : 440 - 441
  • [8] Cost-effectiveness of a pediatric dengue vaccine
    Shepard, DS
    Suaya, JA
    Halstead, SB
    Nathan, MB
    Gubler, DJ
    Mahoney, RT
    Wang, DNC
    Meltzer, MI
    [J]. VACCINE, 2004, 22 (9-10) : 1275 - 1280
  • [9] The projected cost-effectiveness and budget impact of HPV vaccine introduction in Ghana
    Vodicka, Elisabeth
    Nonvignon, Justice
    Antwi-Agyei, Kwadwo Odei
    Bawa, John
    Clark, Andrew
    Pecenka, Clint
    LaMontagne, D. Scott
    [J]. VACCINE, 2022, 40 : A85 - A93
  • [10] Systematic testing in cholera surveillance enhances vaccine impact and cost-effectiveness
    [J]. Nature Medicine, 2024, 30 : 950 - 951
12345